Evidence map›Paper›PMID 40414872›Full record

ArticleThe journal of headache and pain2025

Validation of an 8-item self-administered questionnaire for assessing migraine-related sensory hypersensitivities (MHQ-8).

François Gabrielli, Melissa Zuel, Camille Magaud, Sophia Sickout-Arondo, Bruno Pereira, Jérémie Dassa, Solène De Gaalon, Geneviève Demarquay, Anne Donnet, Anne Ducros and 10 more

Abstract readValidation Study
In one paragraph

Article in The journal of headache and pain, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

François GabrielliUniversité Clermont Auvergne, CHU Clermont-Ferrand, Neuro-Dol, Inserm, Clermont-Ferrand, 63000, France.
Melissa ZuelUniversité Clermont Auvergne, CHU Clermont-Ferrand, Neuro-Dol, Inserm, Clermont-Ferrand, 63000, France.
Camille MagaudUniversité Clermont Auvergne, CHU Clermont-Ferrand, Neuro-Dol, Inserm, Clermont-Ferrand, 63000, France.
Sophia Sickout-ArondoUniversité Clermont Auvergne, CHU Clermont-Ferrand, Neuro-Dol, Inserm, Clermont-Ferrand, 63000, France.
Bruno PereiraBiostatistics Unit (DRCI), CHU Clermont-Ferrand, Clermont-Ferrand, France.
Jérémie DassaService de Neurologie, CH Le Puy en Velay, Le Puy en Velay, France.
Solène De GaalonDepartment of Neurology, CHU de Nantes, Nantes, France.
Geneviève DemarquayHospices Civils de Lyon, University of Lyon, Lyon, France.
Anne DonnetUniversité Clermont Auvergne, CHU Clermont-Ferrand, Neuro-Dol, Inserm, Clermont-Ferrand, 63000, France.
Anne DucrosDepartment of Neurology, Gui-de-Chauliac Hospital, CHU de Montpellier, University of Montpellier, Montpellier, 34000, France.
Pierric GiraudDepartment of Neurology, Annecy Genevois Hospital, Annecy, France.
Evelyne Guégan-MassardierDepartment of Neurology, Rouen University Hospital, Rouen, France.
Christian LucasPain Department, Service de Neurochirurgie, Hôpital Salengro, CHU de Lille, Lille, France.
Jérôme MawetEmergency Headache Center (Centre d'Urgences Céphalées), Department of Neurology, Lariboisière Hospital, Assistance publique des Hôpitaux de Paris, Paris, France.
Mitra NajjarService de Neurologie, CH Vichy, Vichy, France.
Caroline RoosEmergency Headache Center (Centre d'Urgences Céphalées), Department of Neurology, Lariboisière Hospital, Assistance publique des Hôpitaux de Paris, Paris, France.
Elise K Van ObberghenPain Department and FHU InovPain, CHU de Nice, Côte Azur Université, Nice, France.
Christian DualéUniversité Clermont Auvergne, CHU Clermont-Ferrand, Neuro-Dol, Inserm, Clermont-Ferrand, 63000, France.
Radhouane DallelUniversité Clermont Auvergne, CHU Clermont-Ferrand, Neuro-Dol, Inserm, Clermont-Ferrand, 63000, France.
Xavier MoissetUniversité Clermont Auvergne, CHU Clermont-Ferrand, Neuro-Dol, Inserm, Clermont-Ferrand, 63000, France. xavier.moisset@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn addition to headache, migraine patients often experience sensory hypersensitivity to external stimuli. While photophobia and phonophobia are part of the diagnostic criteria of migraine, many patients also exhibit cutaneous allodynia and osmophobia. However, the presence and intensity of these four hypersensitivities are rarely assessed systematically and simultaneously due to the lack of a simple and rapid self-report questionnaire.

methodsWe have identified existing questionnaires for allodynia, photophobia and phonophobia and selected one of each, that were translated in French and validated (according to COSMIN's recommendations). We also proposed a 2-item questionnaire (presence and intensity) for each of these 3 hypersensitivities plus osmophobia, resulting in the 8-item Migraine Hypersensitivity Questionnaire (MHQ-8) exploring these four hypersensitivities. In addition, the headache impact test (HIT-6), the migraine disability assessment (MIDAS) and the hospital anxiety and depression scale (HADS) were also answered. The survey was conducted in Pain and Neurology departments during specialised consultations for headaches. Content validity, structural validity, internal consistency, transcultural validity, reliability, criterion validity, construct validity and responsiveness were tested. Confirmatory factor analysis (CFA) was used to test the dimensionality of the questionnaires.

resultsThe study sample consisted in N = 329 patients with a mean age of 43.7 ± 13.2 and a mean number of 10.2 ± 7.0 migraine days per month; 84% of them were women and 27% had chronic migraine. Overall, 312 to 327 questionnaires were usable for the hypersensitivity questionnaires. The reliability of the MHQ-8 was good to excellent with a Cronbach's alpha of α = 0.88 (photophobia), α = 0.89 (phonophobia), α = 0.91 (allodynia), α = 0.95 (osmophobia), and α = 0.85 for the whole questionnaire. The intraclass correlation coefficient assessing test-retest reliability was 0.83, 0.77, 0.87, and 0.90, respectively; it was 0.88 for the whole questionnaire. The factor analysis on the MHQ-8 items showed excellent exploratory results, and the indicators of the CFA showed good performances with CFI and TLI at 0.999, RMSEA at 0.054 and SRMR at 0.021.

conclusionsThe MHQ-8 developed in this study is valid and reliable. It serves as a new diagnostic tool for the four sensory hypersensitivities that can occur during migraine attacks and may be useful in both clinical research and daily practice.

Indexed as

HyperacusisHyperalgesiaMigraine DisordersPhotophobiaAdultFemaleHumansMaleMiddle AgedPsychometricsReproducibility of ResultsSelf ReportSurveys and QuestionnairesYoung AdultAllodyniaMigraineOsmophobiaPhonophobiaPhotophobiaPsychometric

Identifiers

PMID40414872
PMCPMC12105241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.